Neurology:阵发性偏头痛新的生物标记物——神经酰胺

2015-09-10 MedSci MedSci原创

很多人备受阵发性偏头痛的困扰,但是大家对此知之甚少,近日,发表在Neurology的新进研究中,研究人员发现了阵发性偏头痛患者血液中的生物标志物,这可能会对阵发性偏头痛的诊断和治疗有所帮助,当然还需要进一步的研究进行深入调查。 约翰霍普金斯大学医学院B.Lee Peterlin博士说道:“虽然还需要更多的研究来证实这些初步的研究结果,但是发现这个新的生物标志物还是挺激动人心的”。阵发性偏头痛的患者

很多人备受阵发性偏头痛的困扰,但是大家对此知之甚少,近日,发表在Neurology的新进研究中,研究人员发现了阵发性偏头痛患者血液中的生物标志物,这可能会对阵发性偏头痛的诊断和治疗有所帮助,当然还需要进一步的研究进行深入调查。 


约翰霍普金斯大学医学院B.Lee Peterlin博士说道:“虽然还需要更多的研究来证实这些初步的研究结果,但是发现这个新的生物标志物还是挺激动人心的”。阵发性偏头痛的患者每月头痛时间少于15天,相比之下,慢性偏头痛患者头痛时长超过15天/月。 

偏头痛对公众的健康带来重大影响。因为偏头痛可能会导致他们出现抑郁、焦虑、睡眠障碍和疲劳等表现。除了治疗偏头痛的治疗费用,美国偏头痛委员会估计,美国偏头痛治疗间接消费超过200亿美元/年。 尽管研究人员尚不清楚偏头痛的发生机制,但是更进一步的研究有助于干预这种疾病的继续发展,并且有利于治疗疾病。 

在这项研究中,研究人员对52名诊断有偏头痛且的女性(平均每月疼痛5.6天)进行了神经系统检查,同时对36名未患偏头痛的女性进行了同样的检查,即为对照组。研究人员测量了每个参与者的BMI,并收集了他们的血液样本。通过对血液样本进行分析,研究人员发现了一种被称为神经酰胺的脂质,它的作用是调节大脑的炎症反应。 

研究人员发现,相比没有阵发性偏头痛的女性,患有阵发性性偏头痛的女性神经酰胺水平下降。平均而言,阵发性偏头痛患者血液中总神经酰胺含量约6000毫微克/毫升血,而对照组民众的含量为10500毫微克/毫升血。随着机体总神经酰胺水平的增加,民众患患偏头痛的风险降低。研究人员还发现,两种其他类型的脂质会增加患偏头痛的风险。这两种脂质属于鞘磷脂。 

为了检验实验结果,研究人员对14名参与人员的血液标本进行了检测,事实证明,他们可以准确地分辨出患有偏头痛和未患偏头痛的民众。

这项研究非常重要,它为今后探究偏头痛的发病机制和提供治疗方案并研发药物发挥着重要的作用。

原始出处:

Scientists discover potential biomarker for migraine in the blood,MNT,10,Sep,2015

Interictal, circulating sphingolipids in women with episodic migraine: A case-control study, B. Lee Peterlin et al., Neurology, 9 Sep 2015

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999559, encodeId=67f519995595c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jan 25 10:04:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904434, encodeId=a9e11904434b0, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sun Feb 14 14:04:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345328, encodeId=0d17134532834, content=<a href='/topic/show?id=8907693e0fa' target=_blank style='color:#2F92EE;'>#生物标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69370, encryptionId=8907693e0fa, topicName=生物标记)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278f2500221, createdName=12498fa0m11暂无昵称, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349906, encodeId=2d87134990614, content=<a href='/topic/show?id=3a59693e129' target=_blank style='color:#2F92EE;'>#生物标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69371, encryptionId=3a59693e129, topicName=生物标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510742, encodeId=3d521510e4275, content=<a href='/topic/show?id=38ebe459755' target=_blank style='color:#2F92EE;'>#神经酰胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74597, encryptionId=38ebe459755, topicName=神经酰胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2a10230680, createdName=xugc, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=)]
    2016-01-25 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999559, encodeId=67f519995595c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jan 25 10:04:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904434, encodeId=a9e11904434b0, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sun Feb 14 14:04:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345328, encodeId=0d17134532834, content=<a href='/topic/show?id=8907693e0fa' target=_blank style='color:#2F92EE;'>#生物标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69370, encryptionId=8907693e0fa, topicName=生物标记)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278f2500221, createdName=12498fa0m11暂无昵称, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349906, encodeId=2d87134990614, content=<a href='/topic/show?id=3a59693e129' target=_blank style='color:#2F92EE;'>#生物标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69371, encryptionId=3a59693e129, topicName=生物标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510742, encodeId=3d521510e4275, content=<a href='/topic/show?id=38ebe459755' target=_blank style='color:#2F92EE;'>#神经酰胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74597, encryptionId=38ebe459755, topicName=神经酰胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2a10230680, createdName=xugc, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=)]
    2016-02-14 wjywjy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1999559, encodeId=67f519995595c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jan 25 10:04:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904434, encodeId=a9e11904434b0, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sun Feb 14 14:04:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345328, encodeId=0d17134532834, content=<a href='/topic/show?id=8907693e0fa' target=_blank style='color:#2F92EE;'>#生物标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69370, encryptionId=8907693e0fa, topicName=生物标记)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278f2500221, createdName=12498fa0m11暂无昵称, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349906, encodeId=2d87134990614, content=<a href='/topic/show?id=3a59693e129' target=_blank style='color:#2F92EE;'>#生物标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69371, encryptionId=3a59693e129, topicName=生物标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510742, encodeId=3d521510e4275, content=<a href='/topic/show?id=38ebe459755' target=_blank style='color:#2F92EE;'>#神经酰胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74597, encryptionId=38ebe459755, topicName=神经酰胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2a10230680, createdName=xugc, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1999559, encodeId=67f519995595c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jan 25 10:04:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904434, encodeId=a9e11904434b0, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sun Feb 14 14:04:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345328, encodeId=0d17134532834, content=<a href='/topic/show?id=8907693e0fa' target=_blank style='color:#2F92EE;'>#生物标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69370, encryptionId=8907693e0fa, topicName=生物标记)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278f2500221, createdName=12498fa0m11暂无昵称, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349906, encodeId=2d87134990614, content=<a href='/topic/show?id=3a59693e129' target=_blank style='color:#2F92EE;'>#生物标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69371, encryptionId=3a59693e129, topicName=生物标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510742, encodeId=3d521510e4275, content=<a href='/topic/show?id=38ebe459755' target=_blank style='color:#2F92EE;'>#神经酰胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74597, encryptionId=38ebe459755, topicName=神经酰胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2a10230680, createdName=xugc, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1999559, encodeId=67f519995595c, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Jan 25 10:04:00 CST 2016, time=2016-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1904434, encodeId=a9e11904434b0, content=<a href='/topic/show?id=b8aa619690e' target=_blank style='color:#2F92EE;'>#标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61969, encryptionId=b8aa619690e, topicName=标记物)], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=1072181, createdName=wjywjy, createdTime=Sun Feb 14 14:04:00 CST 2016, time=2016-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1345328, encodeId=0d17134532834, content=<a href='/topic/show?id=8907693e0fa' target=_blank style='color:#2F92EE;'>#生物标记#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69370, encryptionId=8907693e0fa, topicName=生物标记)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=278f2500221, createdName=12498fa0m11暂无昵称, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1349906, encodeId=2d87134990614, content=<a href='/topic/show?id=3a59693e129' target=_blank style='color:#2F92EE;'>#生物标记物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69371, encryptionId=3a59693e129, topicName=生物标记物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1510742, encodeId=3d521510e4275, content=<a href='/topic/show?id=38ebe459755' target=_blank style='color:#2F92EE;'>#神经酰胺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74597, encryptionId=38ebe459755, topicName=神经酰胺)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2a10230680, createdName=xugc, createdTime=Sat Sep 12 13:04:00 CST 2015, time=2015-09-12, status=1, ipAttribution=)]
    2015-09-12 xugc

相关威廉亚洲官网

J Headache Pain:偏头痛可能伴有眩晕症

有证据表明偏头痛可能伴有眩晕症。本研究的目的是以人群为基础的数据集评估眩晕症最常见“良性位置性眩晕(BPPV)”在偏头痛患者中的发病风险。研究人员从台湾地区健康研究中心数据中选取研究对象以及与之匹配的健康人群作为对照组。本研究收纳了8266名偏头痛患者和8266名与之匹配的健康人群。通过Cox风险模型比较两组BPPV的患病率。结果发现,在偏头痛组中,有1.11 %的患者有BPPV,而对照组为0.5

Headache:孕期偏头痛,警惕代谢疾病

偏头痛与一些代谢疾病相关的危险因素(如:脂类代谢异常)息息相关。但是此种联系在偏头痛孕妇中还没有相关信息。Gelaye B等人进行了一项研究评估偏头痛孕妇血脂改变程度及与其的关系。纳入24-28周孕秘鲁孕妇。根据头痛Disorders-II国际分类诊断标准对孕妇评估偏头痛状态。使用标准化的检验放松测定孕妇血清脂质浓度。通过多变量逻辑回归估计孕期偏头痛状态和不同浓度的脂质和脂蛋白间的关系(AORs和

Neurology:偏头痛会增加中风的风险吗?

近日,新的研究表明有偏头痛的老年人患中风的几率可能会增加,但前提是他们是吸烟者。这项研究发表在2015年7月22日美国神经病学学会的医学杂志Neurology上。 “williamhill asia 的发现可能会提供更多的证据有关为什么戒烟对患偏头痛的人非常重要。”医学博士Teshamae Monteith说,“虽然这项调查是在偏头痛老年人和有血管问题的老年人中发现的,但是只患偏头痛的吸烟者会增加中风的风险。早些时候的研

梯瓦在美国推出偏头痛贴片Zecuity

仿制药巨头梯瓦(Teva)近日宣布,在美国推出偏头痛贴片Zecuity(舒马曲坦离子渗透经皮给药系统),该药于2013年获FDA批准用于成人有先兆或无先兆的急性偏头痛治疗,是FDA批准的首款也是唯一一款偏头痛贴片,该药作为一种非口服的差异化治疗选择,将成为偏头痛治疗领域一款改变游戏规则的药物。  Zecuity由NuPathe公司开发,梯瓦在2014年1月耗资1.44亿美元收购NuPa

PLoS One:偏头痛会降低抑郁症状缓解率

偏头痛是临床最常见的原发性头痛类型,临床以发作性中重度、搏动样头痛为主要表现,头痛多为偏侧,一般持续4~72小时,可伴有恶心、呕吐,光、声刺激或日常活动均可加重头痛,安静环境、休息可缓解头痛。目前还没有关于偏头痛对重度抑郁症(MDD)患者的抑郁、焦虑和躯体症状影响,以及随访两年后偏头痛对其抑郁症症状缓解情况的影响的研究,Hung CI等研究者进行的一项研究便是为了探究以上问题。该研究纳入了去精神科